Alvaro Moreno-Aspitia

4PUBLICATIONS
32CO-AUTHORS
Molecular targetsEnvironmental epidemiologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 07, 2025
Pembrolizumab in Combination with Binimetinib in Patients with Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer.

Saranya Chumsri, Joseph J Larson, Emily Liu

|Nov 08, 2023
The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study.

Diogo Martins-Branco, Marie Kassapian, Véronique Debien

|Jun 23, 2023
Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME Model.

Sibel Blau, Julio Antonio Peguero, Halle C F Moore

|Jun 07, 2020
N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancer.

Roberto A Leon-Ferre, Edith A Perez, David W Hillman

Pageof 1

Frequent Collaborators

1 joint publications

Sibel Blau

1 joint publications

Julio Antonio Peguero

1 joint publications

Halle C F Moore

1 joint publications

Mathew Amprayil Cherian